Societal CDMO competitors and similar companiesClear all
Societal CDMO's competitors and similar companies include BTG, Zogenix and Array BioPharma.
 Societal CDMO Recro Gainesville (also known as Recro Pharma) is a clinical-stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of acute post-operative pain. |  Zogenix Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology. |  Array BioPharma Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. | ||
Founding Date | Founding Date 2006 | Founding Date 1948 | Founding Date 2006 | Founding Date 1998 |
Type | Type Public | Type Subsidiary | Type Public | Type Subsidiary |
Tags | ||||
Locations | Locations Gainesville, US HQ Gainesville, US San Diego, US | Locations Emeryville, US HQ Maidenhead, GB | Locations Boulder, US HQ Chicago, US Detroit, US Houston, US Miami, US New York, US Phoenix, US | |
Employees | Employees 21316% decrease | Employees 5284% increase | Employees 14157% increase | Employees 29843% increase |
Valuation ($) | Valuation ($) 97.4 m | Valuation ($) N/A | Valuation ($) 1.5 b | Valuation ($) N/A |
Twitter followers | Twitter followers N/A | Twitter followers 1.1 k | Twitter followers 2 | Twitter followers N/A |
Employee Rating | Employee Rating 3.4 | Employee Rating 3.2 | Employee Rating 2.7 | Employee Rating 3.5 |
Financial | ||||
Revenue (est.) | Revenue (est.) $90.2m (FY, 2022) | Revenue (est.) £731.3m (FY, 2019) | Revenue (est.) $81.7m (FY, 2021) | Revenue (est.) $173.8m (FY, 2018) |
Cost of goods | Cost of goods $67.1m (FY, 2022) | Cost of goods £221m (FY, 2019) | Cost of goods $4.8m (FY, 2021) | Cost of goods $59.4m (FY, 2018) |
Gross profit | Gross profit $23.1m (FY, 2022) | Gross profit £510.3m (FY, 2019) | Gross profit N/A | Gross profit $114.4m (FY, 2018) |
Net income | Net income ($19.9m) (FY, 2022) | Net income £88.3m (FY, 2019) | Net income ($227.4m) (FY, 2021) | Net income ($147.7m) (FY, 2018) |
For sources of this data, please see the company profile
View company profiles
Zogenix
HQ
Emeryville, US
Employees
141
Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology.
View companyArray BioPharma
HQ
Boulder, US
Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.
View company